Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • GSK vs BR✓SelectedUSD · BRGSK vs BR performance historyLatest closeAs of-2.32%11/17
Stock and ETF performance explorer

GSK vs BR

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+103.1%
BR return
+258.9%
Excess return
-155.9%
Maximum drawdown
-37.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioBRExcessAlpha
1D-2.3%-3.4%+1.1%-1.4%
7D-3.0%-2.3%-0.7%-2.4%
30D+0.4%+7.7%-7.3%-1.6%
3M-1.2%+13.0%-14.2%-4.4%
6M+0.9%+31.2%-30.3%-6.4%
YTD+4.0%-13.9%+17.9%+7.6%
1Y+7.3%-14.2%+21.5%+11.1%
3Y+57.1%+9.0%+48.1%+49.5%
5Y+43.0%+18.2%+24.8%+30.6%
10Y+103.1%+246.2%-143.2%+34.9%
All+103.1%+258.9%-155.9%+34.9%

Cumulative growth

Daily Returns

Daily percentage return beside BR.

Daily Out/Under-Performance

Portfolio return minus BR return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × BR return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded BR wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling